[go: up one dir, main page]

MA39126A3 - Synthèse d'enantiomère de progestérone et d'intermédiaires de celui-ci - Google Patents

Synthèse d'enantiomère de progestérone et d'intermédiaires de celui-ci

Info

Publication number
MA39126A3
MA39126A3 MA39126A MA39126A MA39126A3 MA 39126 A3 MA39126 A3 MA 39126A3 MA 39126 A MA39126 A MA 39126A MA 39126 A MA39126 A MA 39126A MA 39126 A3 MA39126 A3 MA 39126A3
Authority
MA
Morocco
Prior art keywords
progesterone
intermediates
enantiomeric synthesis
enantiomeric
synthesis
Prior art date
Application number
MA39126A
Other languages
English (en)
Other versions
MA39126A2 (fr
MA39126B1 (fr
Inventor
Daniel Levy
Faliang Zhang
Xinxi Zhan
Original Assignee
Prevacus Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prevacus Inc filed Critical Prevacus Inc
Publication of MA39126A2 publication Critical patent/MA39126A2/fr
Publication of MA39126A3 publication Critical patent/MA39126A3/fr
Publication of MA39126B1 publication Critical patent/MA39126B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/26—Radicals substituted by doubly bound oxygen or sulfur atoms or by two such atoms singly bound to the same carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
    • C07J15/005—Retrosteroids (9 beta 10 alfa)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • C07J75/005—Preparation of steroids by cyclization of non-steroid compounds

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)

Abstract

La présente invention concerne la synthèse d'enantiomère de progestérone et d'intermédiaires de celui-ci.
MA39126A 2013-12-20 2014-12-17 Synthèse d'enantiomère de progestérone et d'intermédiaires de celui-ci MA39126B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361919420P 2013-12-20 2013-12-20
PCT/US2014/070879 WO2015095339A1 (fr) 2013-12-20 2014-12-17 Synthèse d'enantiomère de progestérone et d'intermédiaires de celui-ci

Publications (3)

Publication Number Publication Date
MA39126A2 MA39126A2 (fr) 2018-08-31
MA39126A3 true MA39126A3 (fr) 2019-04-30
MA39126B1 MA39126B1 (fr) 2020-03-31

Family

ID=53399300

Family Applications (1)

Application Number Title Priority Date Filing Date
MA39126A MA39126B1 (fr) 2013-12-20 2014-12-17 Synthèse d'enantiomère de progestérone et d'intermédiaires de celui-ci

Country Status (18)

Country Link
US (1) US20150175650A1 (fr)
EP (1) EP3083656A1 (fr)
JP (1) JP2017502031A (fr)
CN (1) CN105980396B (fr)
AR (1) AR098879A1 (fr)
AU (1) AU2014364850A1 (fr)
BR (1) BR112016014000A2 (fr)
CA (1) CA2934466A1 (fr)
EA (1) EA201691074A1 (fr)
IL (1) IL246258A0 (fr)
MA (1) MA39126B1 (fr)
MX (1) MX2016008167A (fr)
PH (1) PH12016501201A1 (fr)
SG (1) SG11201604982XA (fr)
TN (1) TN2016000252A1 (fr)
TW (1) TW201538519A (fr)
UY (1) UY35909A (fr)
WO (1) WO2015095339A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017100988A (ja) * 2015-12-01 2017-06-08 アサヒグループホールディングス株式会社 光学活性なヒドロキシ脂肪酸の製造方法
IT201700004904A1 (it) * 2017-01-18 2018-07-18 Ind Chimica Srl PROCESSO PER LA PREPARAZIONE DI 9β,10α-PROGESTERONE (RETROPROGESTERONE)
EP4007765A4 (fr) * 2019-08-02 2023-08-23 Enterin, Inc. Dérivés de squalamine humaine, compositions associées les comprenant, et procédés d'utilisation correspondants
US20230123701A1 (en) * 2019-08-02 2023-04-20 Enterin, Inc. Human aminosterol ent-03 compounds, related compositions comprising the same, and methods of using the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2716095C (fr) * 2008-02-26 2017-02-07 Emory University Analogues steroidiens utilises en neuroprotection
US20110306579A1 (en) * 2009-01-30 2011-12-15 Emory University Methods of neuroprotection using neuroprotective steroids and a vitamin d
AU2012318391A1 (en) * 2011-10-07 2014-05-15 Florida State University Research Foundation Prophylactic and post-acute use of progesterone to better outcomes associated with concussion

Also Published As

Publication number Publication date
SG11201604982XA (en) 2016-07-28
PH12016501201A1 (en) 2016-08-15
JP2017502031A (ja) 2017-01-19
CN105980396B (zh) 2019-03-22
CN105980396A (zh) 2016-09-28
MA39126A2 (fr) 2018-08-31
MA39126B1 (fr) 2020-03-31
CA2934466A1 (fr) 2015-06-25
TN2016000252A1 (en) 2017-10-06
MX2016008167A (es) 2017-04-27
IL246258A0 (en) 2016-08-02
TW201538519A (zh) 2015-10-16
UY35909A (es) 2015-07-31
EA201691074A1 (ru) 2017-02-28
AU2014364850A1 (en) 2016-07-07
BR112016014000A2 (pt) 2017-08-08
US20150175650A1 (en) 2015-06-25
AR098879A1 (es) 2016-06-22
EP3083656A1 (fr) 2016-10-26
WO2015095339A1 (fr) 2015-06-25

Similar Documents

Publication Publication Date Title
MA39095A1 (fr) Anticorps et immunoconjugués anti-cd33
MA43018B1 (fr) Anticorps anti-pd1 et procédés d'utilisation
TWD179057S (zh) 充電器
MA40576B1 (fr) Anticorps et immunoconjugués anti-her2
TWD180147S (zh) 淨水器
MA38632B1 (fr) Anticorps anti-récepteur de transferrine et procédés d'utilisation
UY34721A (es) Anticuerpos anti-hla-b*27 y usos de éstos.
JOP20140114B1 (ar) مركبات حلقية غير متجانسة واستخداماتها
TWD182434S (zh) 修枝剪刀(一)
TWD174041S (zh) 手錶
TWD174040S (zh) 錶
EA201600026A1 (ru) Бактериальная гиалуронидаза и способ ее производства
RS54716B1 (en) HETEROCYCLIC COMPOUNDS AND THEIR APPLICATIONS
IN2013MU00848A (fr)
PH12016500683B1 (en) Synthetic route to 2`-deoxy-2`,2`-difluorotetrahydrouridines
TWD176865S (zh) 滴定儀器
TWD187227S (zh) 淨水器
MA39126A2 (fr) Synthèse d'enantiomère de progestérone et d'intermédiaires de celui-ci
EP2726636A4 (fr) Elucidation de l'identite de metabolites inconnus
MA39411A (fr) Synthèse de l'énantiomère de la progestérone et ses intermédiaires
EA201690263A1 (ru) Улучшенные способы получения перампанеля
TWD166471S (zh) 手錶
TWD173011S (zh) 手錶
MX2015012902A (es) Sintesis de ent-progesterona e intermediarios de la misma.
MA39355B2 (fr) Anticorps anti-ox40 et procédés d'utilisation correspondants